Skip to main content

Table 4 Analysis of tumour volumes detected via 7 T in vivo MRI in a CT1258 based in vivo model of prostate cancer

From: Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer

Animal Day 17; Day 22; Day 24; Day 25; Day 39; Day 43; Day 53; Day 59; Day 66;
Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3] Tumour volume [mm3]
5   7.26 13.42       
(♂, intact)          
6   0.531 11.78    699.19    
(♂, intact)          
7     1.37 1.51   2.14 11.43 36.50
(♂, intact)          
8 1.65 11.27 24.72    1,928.83    
(♂, castrated)          
9   8.66 32.42    1,533.26    
(♂, castrated)          
  1. The male animals received 103 MnCl2 labelled cells. The tumour volumes are displayed for the respective days of MRI measurements after subcutaneous injection.
  2. ♂ = male animal.
\